Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist

Molecular Imaging and Biology

Volumn 14, Issue 1, 2012, Pages 79-87

  Connolly, Brett M ^a   Vanko, Amy ^a   McQuade, Paul ^a   Guenther, Ilonka ^a,b   Meng, Xiangjun ^a   Rubins, Daniel ^a   Waterhouse, Rikki ^a,c   Hargreaves, Richard ^a   Sur, Cyrille ^a   Hostetler, Eric ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Maccine Pte Ltd   (Singapore)

^c ABBOTT LABORATORIES   (United States)

Author keywords

cell; Autoradiography; Exendin 4; GLP 1R; Imaging; Pancreas

Indexed keywords

COPPER 64; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN ANTIBODY; LYSINE; LYSINE 40; TETRAXETAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; AUTORADIOGRAPHY; CELL LABELING; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MALE; MOLECULAR IMAGING; NONHUMAN; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; RAT; ZUCKER DIABETIC FATTY RAT;

ANIMALS; AUTORADIOGRAPHY; COPPER RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; MALE; MOLECULAR IMAGING; PEPTIDES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RECEPTORS, GLUCAGON; VENOMS;

ANIMALIA; RATTUS;

EID: 84861481526     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0481-7     Document Type: Article

References (31)

1. Centers for Disease Control and prevention (2008) National diabetes fact sheet: general information and health estimates on diabetes in the United States, 2007. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta
2. The National Institute of Diabetes and Digestive and Kidney Disease (2008) National Diabetes Statistics, 2007. US Department of Health and Human Services, National Institutes of health, Bethesda
3. 11C]DTBZ. Nucl Med Biol 33:855-864
4. 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. J Nucl Med 49(7):1171-1176
5. Fagerholm V, Mikkola KK, Ishizu T, Arponen E, Kauhanen S, Någren K, Solin O, Nuutila P, Haaparanta M (2010) Assessment of islet specificity of dohydrobenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 51(9):1439-1446
6. 18F]FP-(+)- DTBZ in rodent models of diabetes. Mol Imaging Biol. doi:10.1007/s11307-010-0406-x
7. 11C-dihyrotetrabenazine cell imaging. J Nucl Med 51(9):1335-1336
8. Gotthardt M, Lalyko G, van Eerd-Vismale J, Keil B, Schurrat T, Hower M, Laverman P, Behr TM, Boermann O, Göke B, Béhé M (2006) A technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents. Reg Peptides 137(3):162-167 (Pubitemid 44838980)
9. Mukai E, Toyoda K, Kimura H, Kawashima H, Fujimoto H, Ueda M, Temma T, Hirao K, Nagakawa K, Saji H, Inagaki N (2009) GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging. Biochem Biophys Res Commun 389:523-526
10. Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153-165
11. Doyle ME, Egan JM (2007) Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharm & Therap 113(3):546-593 (Pubitemid 46365961)
12. Wang Q, Brubaker PL (2002) Glucagon-like petide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologica 45:1263-1273
13. Runge S, Thøgersen H, Madsen K, Lau J, Rudolph R (2008) Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283(17):11340-11347
14. Mann R, Nasr N, Hadden D, Sinfield F, Abidi F, Al-Sabah S et al (2007) Peptide binding at the GLP-1 receptor. Biochem Soc Trans 35(4):713-716 (Pubitemid 47310351)
15. 64Cu using a biomedical cyclotron. Nucl Med Biol 15(24):35-43
16. Clark JB, Palmer CJ, Shaw WN (1983) The diabetic zucker fatty rat. Proc Soc Exp Biol Med 173:68-75 (Pubitemid 13088195)
17. Peterson RG, Shaw WN, Neel M-A, Little LA, Eichberg J (1990) Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32(3):16-27
18. Abeeleh MA, Ismail ZB, Alzaben KR, Abu-Halaweh SA, Al-Essa MK, Abuabeeleh J, Alsmady MM (2009) Induction of Diabetes Mellitus in Rats Using Intraperitoneal Streptozotocin: A Comparison between 2 Strains of Rats. Eur J Sci Res 32(3):398-402
19. Schneider S (2008) Efforts to develop methods for in vivo evaluation of the native β-cell mass. Diab Obesity and Metab 10(4):109-118
20. Moore A (2009) Advances in beta cell imaging. Eur J Radiol 70 (2):254-257
21. Murthy R, Harris P, Simpson N, Van Heertum R, Leibel R, Mann JJ, Parsey R (2008) Whole body[11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human dosimetry estimates. Eur J Nucl Med Mol Imaging 35(4):790-797
22. 64Cu Labeled Affibody Protein. Bioconjug Chem 21(5):947-954
23. 64Cu-labeled E. coli heat-stable enterotoxin analogues for pet imaging of colorectal cancer. Bioconjug Chem 21 (7):1171-1176
24. 3expression. Bioconjug Chem 21(8):1417-1424
25. Orskov C, Poulsen SS (1991) Glucagonlike peptide-1- (7-36)-amide receptors only in islets of Langerhans. Autoradiographic survey of extracerebral tissues in rats. Diabetes 40:1292-1296
26. Heller RS, Aponte GW (1995) Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7-36) amide. Am J Physiol 269:G852-860
27. Heller RS, Kieffer TJ, Habener JF (1997) Insulinotropic glucagon-like petide 1 expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 46:785-791 (Pubitemid 27188255)
28. Bullock BP, Heller RS, Habener JF (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968-2978 (Pubitemid 26192194)
29. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F (1996) Expression and functional activity of glucagon, glucagon-like peptide I, and glucose dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261 (Pubitemid 26048675)
30. Tornehave D, Kristensen P, Rømer J, Bjerre Knudsen L, Heller RS (2008) Expression of the GLP-1 receptor in mouse, rat and human pancreas. J Histo Cyto 56(9):841-851
31. Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim C (2005) β-cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 54:1808-1815 (Pubitemid 40770771)